As I See It

The deal of the year

By Paul S. Koch, MD

ASC Adviser

CMS: rewriting the rules

By MICHAEL A. ROMANSKY, JD

At Press Time

ISTA Pharmaceuticals Makes Steady Progress

By Jerry Helzner, contributing editor

Benchmarking: A Tool for Effective Decision-making

Use it to build an efficient practice

By SHERRI DUMFORD, C.H.B.M.E., M.B.A.

Coding & Reimbursement

Medicare Reimbursement for Testing With the Visante OCT

By Suzanne L. Corcoran, COE

Common Errors in the Refractive Process

The good news: They are easily avoided

By SUSAN K. CORWIN, C.O., C.O.M.T.

Flap-cutting Technologies Provide Choices

Laser microkeratomes are gaining ground, but one surgeon says that mechanicals still deliver

By By ReN

Help Desk

Video journal teaches new techniques

Marketplace

Focus on specialty contact lenses

MD Toolkit

Top three tools I use right now

By JOHNNY GAYTON, MD

Medicare Reimbursement 2008

Is the glass half full or half empty?

By DONNA M. McCUNE, CCS

New M.D.

A Lesson Learned in Sensitivity

By Allen Hu, M.D.

Spotlight on Technology & Technique

Red reflex technology delivers increased visual detail

By LESLIE GOLDBERG, Associate

Viewpoint

From the Chief Medical Editor

What Do You Need From OCT?

For the comprehensive ophthalmologist, historical data may trump a more vivid image

By LESLIE GOLDBERG, Associate

Adjusting to Accommodate Retina Procedures

Learn about the management, investment and real costs of moving retina procedures to the ASC

Evaluating the Spectral Domain Advantage

Learn how the Cirrus HD-OCT can improve the way we evaluate, track and treat retinal disease

By Ursula Schmidt-Erfurth, M.D.

ASC Hot-button Issues

What to look forward to - and look out for - in 2008

Exploring New Dimensions in OCT Imaging

Spectral domain OCT offers clinicians new perspectives in visualizing retinal disease

By Peter K. Kaiser, MD

Enhancing ASC Management and Growth

Satisfied surgeons and an efficient center equal maximum profits. Here's how you can use technology to make it happen.

Turning Our Attention to Dry AMD

Learn how spectral domain technology may factor into new drug development and improved outcomes

By Philip J. Rosenfeld, MD, PhD

Infection and How It Affects the ASC

How will the TASS outbreak and other infections change regulation?

Is Your Center Accredited?

How to integrate your patients' high expectations with the new billing considerations

Taking on Premium IOLs

How to integrate your patients' high expectations with the new billing considerations